LIfT BioSciences: Funding, Investors & Team (Oct 2026)
LIfT Biosciences® has a breakthrough allogeneic innate immuno-cell therapy platform called Neutrophil Only Leukocyte Infusion Therapy (N-LIfT®) that allows us to produce different types of Immunomodulatory Alpha Neutrophils (IMAN®s) at scale from iPSCs for a wide range of different purposes as a mono or combo. LIfT BioSciences was founded in 2016 and headquartered in London, England.
LIfT BioSciences has raised $15.2M across 3 funding rounds on record, the most recent an undisclosed round of $13.9M announced in Jul 2025.
That round is above the $8.4M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
LIfT BioSciences Company Profile and Key Stats
Latest funding round on record: Jul 2025.
LIfT BioSciences Funding Rounds
1 of 3 rounds was announced without a disclosed amount and is excluded from the total.
LIfT BioSciences announced an undisclosed round in Dec 2022; the amount was not disclosed.
1.4 years later, an undisclosed round of $1.3M was announced in May 2024.
1.2 years later, an undisclosed round of $13.9M was announced in Jul 2025.
LIfT BioSciences Founders and Leadership Team
Contact details for the LIfT BioSciences team: 1 of 1 has an email address on file.
Start 14-day free trial →LIfT BioSciences Funding Compared to Other Biotechnology Startups
LIfT BioSciences' latest round of $13.9M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like LIfT BioSciences in Biotechnology and London
Companies Similar to LIfT BioSciences
Microbiotica develops treatments involving live bacteria found in the human microbiome, aiming to identify…
OMass Technologies is a drug discovery company exploiting novel mass spectrometry platforms to develop…
HydRegen, based in Oxford, UK, is a biotech firm that offers eco-friendly alternatives for the production of…
R1 Therapeutics is a clinical‑stage biopharmaceutical company focused on discovering and developing new drug…
The perfect package for any general surgical trainee or resident. Progress from beginner to advanced surgical…
Argonaute RNA company research projects build on existing intellectual property.
An innovative C elegans company that serves the biotech, nutrition, and other industries and fields of study…
ViaNautis, previously known as SomaServe, was established in 2018 as a separate entity from UCL under the…
Alchemab is harnessing the naturally protective power of patient antibodies to keep people free of…
Biodexa Pharmaceuticals is an international specialty pharmaceutical company focused on oncology and other…
Concert Bio helps businesses create optimal microbial communities.
RQ Bio is a biotechnology company that develops long-acting monoclonal antibodies against seasonal influenza…
LIfT BioSciences Funding FAQs
What does LIfT BioSciences do?
LIfT Biosciences® has a breakthrough allogeneic innate immuno-cell therapy platform called Neutrophil Only Leukocyte Infusion Therapy (N-LIfT®) that allows us to produce different types of Immunomodulatory Alpha Neutrophils (IMAN®s) at scale from iPSCs for a wide range of different purposes as a mono or combo. LIfT BioSciences was founded in 2016 and headquartered in London, England.
How much funding has LIfT BioSciences raised?
LIfT BioSciences has raised $15.2M across 3 rounds on record. The most recent is an undisclosed round of $13.9M announced in Jul 2025.
When did LIfT BioSciences last raise funding?
LIfT BioSciences' most recent funding round on record is an undisclosed round of $13.9M, announced in Jul 2025.
Who founded LIfT BioSciences?
FundedIQ lists Alex Blyth (Founder) at LIfT BioSciences.
Where is LIfT BioSciences headquartered?
LIfT BioSciences is based in London, England, United Kingdom.
How many employees does LIfT BioSciences have?
LIfT BioSciences is in the 11-50 employee band.
How does LIfT BioSciences' funding compare to other Biotechnology startups?
LIfT BioSciences' latest round of $13.9M is above the $8.4M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.
About FundedIQ's LIfT BioSciences Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for LIfT BioSciences is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.